Riskpilot← Back to searchSign inGet full accessSymbiom AB
ABActiveOrg 5569521007Husby Berget 1Business and other management consultancy activities · NACE 7020Est. 20131 employees
Revenue 2024
SEK 158K
-58% vs 2023
EBITDA margin
-53.8%
-171% vs 2023
Equity ratio
81.0%
Financial strength
Net profit 2024
SEK 115K
0% vs 2023
| Revenue | SEK 158K | -58% |
| EBITDA | SEK -85K | -171% |
| Net profit | SEK 115K | +0% |
| Total assets | SEK 348K | -2% |
| Equity | SEK 282K | +43% |
| Employees | 1 | — |
Legal name
Symbiom AB
Org number
5569521007
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 december 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska äga och förvalta värdepapper, bedriva konsultverksamhet inom livs- och fodermedelsindustrin, artistframträdanden och uthyrning av musikinstrument, ljud- och ljusutrustning samt därmed förenlig verksamhet.
Address
Husby Berget 1
Email
matilda.olstorpe@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 122 | 35 | −0 | 375 | 158 |
| Staff expenses | — | — | −8 | −153 | −138 |
| EBITDA | 28 | −7 | −55 | 119 | −85 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 28 | −7 | −55 | 119 | −85 |
| Net financials | — | — | 0 | 0 | 230 |
| Profit before tax | 28 | −7 | −55 | 120 | 146 |
| Tax | −0 | −0 | — | −4 | −30 |
| Net profit | 28 | −7 | −55 | 115 | 115 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 160 | 198 | 145 | 354 | 348 |
| Equity | 144 | 137 | 81 | 197 | 282 |
| Long-term debt | 0 | 50 | 50 | 50 | 0 |
| Short-term debt | 17 | 11 | 14 | 107 | 66 |
| Total debt | 17 | 61 | 64 | 157 | 66 |
EBITDA margin
-53.8%
This company
15.8%
Market median
-441% vs market
20202024
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
40.8%
This company
18.4%
Market median
+122% vs market
20202024
Net profit margin
73.0%
This company
8.1%
Market median
+801% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Symbiom AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Maria Matilda Olstorpe | Board of Directors | 0 companies |
| Karl Joakim Oltner | Deputy Board Member | 0 companies |